Page 106 - Quest Diagnostics News Today

TUESDAY, July 25, 2023 (HealthDay News) -- Results from more than 26,000 respiratory tests in late 2022 found simultaneous infections with COVID-19, influenza or respiratory syncytial virus (RSV) in more

UniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive cases of the disease which kills more than 300,000 men each year.

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) was the recipient of a large decrease in short interest in June. As of June 30th, there was short interest totalling 3,370,000 shares, a decrease of 10.4% from the June 15th total of 3,760,000 shares. Approximately 3.0% of the shares of the company are short sold. Based […]

The Dow was the star show, with a weekly advance of more than 2% and the first 10 session winning streak since 2017.

/PRNewswire/ -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and...

The concentration of antigens in the blood can be determined by using one of the most common in-vitro assay methods: radioimmunoassay (RIA). Competitive

Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and...

Q4HE Collaborates With Western University of Health Sciences To Support ...

DUBLIN--(BUSINESS WIRE)--The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global MRD testing market is projected to reach $6.67 billion by 2033...

On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes Quest Diagnostics Incorporated (NYSE: DGX) here.